Epigenetic Regulation and Drug Discovery for Cancer Therapy-Reference-Cited by-同舟云学术

Epigenetic Regulation and Drug Discovery for Cancer Therapy

Published:2019-07-30 Issue:12 Volume:19 Page:971-971
ISSN:1568-0266
Container-title:Current Topics in Medicinal Chemistry
language:en
Short-container-title:CTMC

Author:

Yu Bin¹,Ouyang Liang²

Affiliation:

1. Children's Hospital Affiliated to Zhengzhou University Zhengzhou Children's Hospital. School of Pharmaceutical Sciences Zhengzhou University Zhengzhou 45001, China

2. State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and Collaborative Innovation Center of Biotherapy Sichuan University Chengdu 610041, China

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,General Medicine

Reference6 articles.

1. Duan Y-T.; Sangani C.B.; Liu W.; Soni K.V.; Yao Y.; New promises to cure cancer and other genetic diseases/disorders: Epi-drugs through epigenetics. Curr Top Med Chem 2019,19(12),972-994

2. Bai Y.; Ahmad D.; Wang T.; Cui G.; Li W.; Research advances in the use of histone deacetylase inhibitors for epigenetic targeting of cancer. Curr Top Med Chem 2019,19(12),995-1004

3. Peng X.; Liao G.; Sun P.; Yu Z.; Chen J.; An overview of HDAC inhibitors and their synthetic routes. Curr Top Med Chem 2019,19(12),1005-1040

4. Lu H.; Bai L.; Zhou Y.; Lu Y.; Jiang Z.; Shi J.; Recent study of dual HDAC/PARP inhibitor for the treatment of tumor. Curr Top Med Chem 2019,19(12),1041-1050

5. Wang T.; Xu Z.; Lu Y.; Qi B.; Bai L.; Liu W.; Zhang C.; Jiang Z.; Recent progress on discovery of Sirt2 inhibitors for the treatment of various cancers. Curr Top Med Chem 2019,19(12),1051-1058

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?;European Journal of Medicinal Chemistry;2023-10

2. In Silico Discovery of Class IIb HDAC Inhibitors: The State of Art;Challenges and Advances in Computational Chemistry and Physics;2023

3. Promoter Hypomethylation and miR-145-5p Downregulation- Mediated HDAC11 Overexpression Promotes Sorafenib Resistance and Metastasis of Hepatocellular Carcinoma Cells;Frontiers in Cell and Developmental Biology;2020-08-12

4. Identification and biological evaluation of natural product Biochanin A;Bioorganic Chemistry;2020-04

5. Discovery of class I histone deacetylase inhibitors based on romidpesin with promising selectivity for cancer cells;Future Medicinal Chemistry;2020-02